These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 185101)

  • 1. [In vitro assay for ACTH-releasing activity using ACTH radioimmunoassay: ACTH releasing activities by various drugs (author's transl)].
    Hashimoto K; Takahara J; Hosogi H; Ofuji N; Yasuhara T
    Nihon Naibunpi Gakkai Zasshi; 1976 Feb; 52(2):114-24. PubMed ID: 185101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of corticotropin-releasing hormone, lysine vasopressin, oxytocin, and angiotensin II on adrenocorticotropin secretion from porcine anterior pituitary cells.
    Abraham EJ; Minton JE
    Domest Anim Endocrinol; 1996 May; 13(3):259-68. PubMed ID: 8738867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of synthetic ovine corticotropin-releasing factor (CRF) on ACTH release in vitro].
    Murakami K; Hashimoto K; Kageyama Z; Takahara J; Ota Z
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):983-92. PubMed ID: 6313440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arginine vasopressin in control of ACTH and LH release during stress.
    Ono N; Bedran de Castro J; Khorram O; McCann SM
    Life Sci; 1985 May; 36(18):1779-86. PubMed ID: 2984509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines.
    Bény JL; Baertschi AJ
    Endocrinology; 1981 Sep; 109(3):813-7. PubMed ID: 6266808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF).
    Hashimoto K; Yunoki S; Takahara J; Ofuji T
    Endocrinol Jpn; 1979 Feb; 26(1):103-9. PubMed ID: 35343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.
    Gaillard RC; Turnill D; Sappino P; Muller AF
    Endocrinology; 1990 Jul; 127(1):101-6. PubMed ID: 2163305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands.
    Dupouy JP; Chatelain A
    J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
    Sato N; Yanaihara T; Kanazawa M; Okinaga S; Arai K
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):845-50. PubMed ID: 797581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
    van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
    J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats.
    Murakami K; Hashimoto K; Ota Z
    Neuroendocrinology; 1984 Jul; 39(1):49-53. PubMed ID: 6087183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandin E1 and indomethacin on ACTH, prolactin, GH and LH from rat pituitary in vitro.
    Takahara J; Mori M; Ofuji N; Hashimoto K; Yamauchi J
    Endocrinol Jpn; 1977 Feb; 24(1):97-103. PubMed ID: 193686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress].
    Fujieda K
    Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH secretion from isolated hypophysial anterior lobes of male and female newborn rats: effects of corticotrophin-releasing factor, arginine vasopressin and oxytocin alone or in combination.
    Hary L; Dupouy JP; Chatelain A
    J Endocrinol; 1993 Apr; 137(1):123-32. PubMed ID: 8388013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.